Rafferty Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-60,614
| Closed | -$1.13M | – | 1171 |
|
|
2024
Q2 | $1.13M | Sell |
60,614
-80,249
| -57% | -$1.5M | ﹤0.01% | 789 |
|
|
2024
Q1 | $2.78M | Buy |
140,863
+45,008
| +47% | +$888K | 0.01% | 607 |
|
|
2023
Q4 | $1.68M | Sell |
95,855
-43,251
| -31% | -$759K | 0.01% | 716 |
|
|
2023
Q3 | $2.42M | Buy |
139,106
+19,731
| +17% | +$343K | 0.01% | 560 |
|
|
2023
Q2 | $1.68M | Sell |
119,375
-9,913
| -8% | -$140K | 0.01% | 690 |
|
|
2023
Q1 | $1.39M | Buy |
129,288
+37,976
| +42% | +$409K | 0.01% | 714 |
|
|
2022
Q4 | $1.37M | Buy |
+91,312
| New | +$1.37M | 0.01% | 681 |
|
|
2022
Q1 | – | Sell |
-88,024
| Closed | -$1.04M | – | 1279 |
|
|
2021
Q4 | $1.04M | Buy |
88,024
+1,819
| +2% | +$21.4K | 0.01% | 847 |
|
|
2021
Q3 | $982K | Sell |
86,205
-16,876
| -16% | -$192K | 0.01% | 829 |
|
|
2021
Q2 | $1.44M | Buy |
103,081
+38,673
| +60% | +$539K | 0.01% | 776 |
|
|
2021
Q1 | $1.19M | Buy |
64,408
+47,641
| +284% | +$882K | 0.01% | 732 |
|
|
2020
Q4 | $296K | Buy |
+16,767
| New | +$296K | ﹤0.01% | 812 |
|